Dr. Marinely Cruz-Amy, M.D.
What this data tells you about Dr. Cruz-Amy
Dr. Marinely Cruz-Amy is a medical oncology in Orange City, FL, with 18 years in practice. Based on federal Medicare data, Dr. Cruz-Amy performed 2,159 Medicare services across 522 unique beneficiaries.
Between the years covered by Open Payments, Dr. Cruz-Amy received a total of $4,932 from 58 pharmaceutical and/or device companies across 292 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Cruz-Amy is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 1,020 | $18 | $51 |
| Complete blood count (CBC) with differential | 254 | $8 | $29 |
| Blood draw (venipuncture) | 216 | $8 | $9 |
| Drug injection, under skin or into muscle | 171 | $10 | $69 |
| Hospital follow-up visit, high complexity | 146 | $93 | $285 |
| Office visit, established patient (20-29 min) | 98 | $69 | $239 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 68 | $1 | $6 |
| Initial hospital admission, high complexity | 59 | $135 | $556 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 52 | $48 | $189 |
| Injection of additional new drug or substance into vein | 45 | $12 | $61 |
| Administration of chemotherapy into vein, 1 hour or less | 30 | $95 | $378 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (95%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Cruz-Amy is a mixed practice specialist, with moderate Medicare volume, and low-engagement industry engagement, with 18 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Cruz-Amy experienced with denosumab injection (prolia/xgeva)?
Does Dr. Cruz-Amy receive payments from pharmaceutical companies?
How do Dr. Cruz-Amy's costs compare to other medical oncologys in Orange City?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology